Clonidine hydrochloride .1 mg/1 TABLET, EXTENDED RELEASE
Ajanta Pharma USA Inc.
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Clonidine hydrochloride extended-release is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical Studies ( 14 )] . Clonidine hydrochloride extended-release tablets are a centrally acting alpha 2 -adrenergic agonist indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy or as adjunctive therapy to stimulant medications. ( 1 )
Source: FDA. For professional use only. Not a substitute for prescribing information.
Other Clonidine hydrochloride NDC Codes
Wholesale and compliance resources
Order NDC 27241-0108-06 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).